A detailed history of Hilton Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hilton Capital Management, LLC holds 3,432 shares of ABBV stock, worth $585,739. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,432
Previous 3,575 4.0%
Holding current value
$585,739
Previous $613,000 10.44%
% of portfolio
0.06%
Previous 0.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $23,429 - $28,504
-143 Reduced 4.0%
3,432 $677,000
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $65,321 - $76,280
422 Added 13.38%
3,575 $613,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $121,143 - $138,031
758 Added 31.65%
3,153 $574,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $110,454 - $126,684
-823 Reduced 25.57%
2,395 $321,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $25,046 - $31,842
-182 Reduced 5.35%
3,218 $493,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $15,573 - $19,322
-118 Reduced 3.35%
3,400 $551,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $277,706 - $351,379
-2,585 Reduced 42.36%
3,518 $476,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $278,129 - $315,718
2,614 Added 74.92%
6,103 $658,000
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $105 - $117
1 Added 0.03%
3,489 $393,000
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $14,731 - $16,217
144 Added 4.31%
3,488 $377,000
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $32,115 - $43,359
-399 Reduced 10.66%
3,344 $358,000
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $9,450 - $11,091
110 Added 3.03%
3,743 $328,000
Q2 2020

Jul 14, 2020

SELL
$73.37 - $98.18 $20,323 - $27,195
-277 Reduced 7.08%
3,633 $357,000
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $41,731 - $63,270
647 Added 19.83%
3,910 $298,000
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $79,559 - $99,545
1,103 Added 51.06%
3,263 $289,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $230,025 - $308,025
-2,500 Reduced 53.65%
2,160 $204,000
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $325,501 - $415,765
4,660
4,660 $414,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hilton Capital Management, LLC Portfolio

Follow Hilton Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilton Capital Management, LLC with notifications on news.